Only good analysis for small biotech is comparative analysis based on various factors (Economics ABC) and most importantly peer prices!
Wait for shorts to cover as this climb continues. The average of shorts is probably in the $7s!
So people, now with this wonderful news known to public (i.e., the 55 patient information arm data), you may wonder why the price has not reached much much higher, and why?
The simple answer to that question is this, thinking if you manage a multi-billion dollar investment fund, can you put all the money you want to invest in a single company in one or two days?
Let alone it takes time for them to ascern and come up with a strategy, tactics or even some dirty tricks in order to achieve their goals.
At this point of time, some funds may be still in meetings debating! LOL
Now with the just published amazing treatment data from 55-patient information arm, no one can deny the huge potential of DCVax platform. Nobody!
Of course not and definitely impossible. The point I tried to make is that even they are all pseudo (which of course are impossible and would never be a fact at any chance), the data is still great, and if PhIII can just repeat that, we go directly to FDA approval!
from Ihub, Anhe made a good point:
"Anhe Thursday, 03/26/15 11:10:25 AM
Post # of 31661
He was emphasizing the long tail effect, at least in my opinion. He seemed very happy with this results. Many patients lived much longer (or ar still alive in this indeterminate group).
Especially this case (indeterminate group) shows again, that using the median OS alone isn't such a good thing. The mOS in this group in "only" 21.5 months, but 9 of those 25 patients are still alive (27 to 40 months now).
Maybe 4 or 5 of these 9 are completely cured, that would make 16 to 20 percent from this group of 25. That would really be a great success. But the media OS would still be at 21.5 months and still sound disappointing."
BTW: shortable shares for today is zero again. Watch for how the market reacts. The big guys are in meeting perhaps planning how to suppress interests of retail investors.
No doubt. The market needs some time to figure it out though. LOL!
Yes, the idiot in IHub has made the number of pseudo progression patients at 24 as if it is a fact. Now we know only one patient is confirmed to be pseudo pression. Yes, as you said for most conservative point of view (impossible) by assuming all those 25 indeterminate patients are pseudo, the results are sill unbelievable positive and unheard of.
DCVax we believe! When its day comes with great treatments for patients with both operable and inoperable cancers of various types and forms, today's big pharms will be tomorrow's small pharms compared to Northwest Biotherapeutics!
Nothing really have left for shorts to be hoping for, except FUD since AF has tried thousands of times, his boss Cramer have tried several times. Both have failed. Potential investors should be very happy to have opportunity of analyzing this wonderful stock, and will find what a once-for-life opportunity to own this stock at such artificially suppressed price!
Today, longs and shorts will have opportunity of analyzing some detail data from 55 information arm from Doc. Bosch. Let data speak for itself!
as of 26 March 2015 at 5:36 am. No shortable shares available. Run, run, run shorties for cover or not!
To entertain myself and to make somebody who sold misery, I bought just 3k around $7.3. Thank you.
BTW, that shortable shares for today is still sitting at just 1k. LOL
For instance, Kite down more than 9%, Juno 8%, cldx 8%, and blue 7%. NWBO down about 3% in this non-distinguishable sinking. In discretion, nwbo should be up but that's the general trend which needs to be settled first.
Good time to buy, particularly for those who have been on sideline and those who want to buy back!
The big pharms are scared for the potential huge successes of DCVax platform, which will make a big chunk of their business useless, so it comes Cramer, the big pharm boy, and so it comes AF, the little warrior against small pharms.
So it comes dozens of contractors, making a dime or a buck commission per post for selling their souls to the corrupted part of America.
But, NWBO has at this stage well developed enough to weather any storms, and has not put itself for sale.
We are talking about billions or even 200 billion potential market cap for NWBO.